Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-08
1995-12-12
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514321, 546198, 548161, 548178, C07D41710, A61K 31425
Patent
active
054750148
ABSTRACT:
An oxazolidone derivative represented by formula (I) which has a monoamine oxidase inhibition effect: ##STR1## {wherein A and B each represents a nitrogen atom, a sulfur atom or an oxygen atom, with the proviso than at least one of A and B must be a nitrogen atom,
R.sup.1 represents a group of the formula: ##STR2## (in which n and m each represents 0 or an integer of 1 to 4, and R.sup.3 and R.sup.4 each represents a hydrogen atom, a hydroxyl group, a lower alkyl group, etc. ), a group represented by the formula: ##STR3## (in which p and q each represents 0 or an integer of 1 to 4 and X represents an oxygen atom, sulfur atom, etc.) and a group represented by the formula: ##STR4## R.sup.2 represents a hydrogen atom or a lower alkyl group}.
REFERENCES:
patent: 4801600 (1989-01-01), Wang
patent: 5322835 (1994-06-01), Takahashi
Akasaka Kozo
Iimura Youichi
Kagaya Takaki
Kajiwara Akiharu
Komatsu Mariko
Eisai Co. Ltd.
Gerstl Robert
LandOfFree
Oxazolidone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidone derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1360100